The blueprint, a basic outline and core message the FDA thinks should be conveyed to prescribers, is open to stakeholder comment. The final blueprint will be published to the FDA website for use by providers of continuing education in creating courses for the safe prescribing of opioids.
Related Articles on Opioid:
Opioid Abuse Increasing in Older White Women
Oregon’s High Rate of Pain Drug Abuse Linked to Heavy Prescribing
Opioid Pain Reliever Overdose Kills More than Heroin and Cocaine Combined
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
